| Title | Guidance: Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products |
| ToC Doc | Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products |
| Docket Number | 2021-26640 |
| Type | Notice |
| Subject | Guidance: Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products |
| Publication Date | 2021-12-09 |
| Last Updated Date | 2021-12-08 08:15:18 -0500 |
| Last Public Inspection | 2021-12-08 |
| Filed At | 2021-12-08T08:45:00.000-05:00 |
| 2021-26640_PI.pdf (79268 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 6 |
| Filing Type | regular |
| Agencies | Food and Drug Administration |
You can find the raw source document below...